| Literature DB >> 26725085 |
Riley Bove1, Allison McHenry2, Kerstin Hellwig3, Maria Houtchens2,4, Neda Razaz5, Penelope Smyth6, Helen Tremlett7, A D Sadovnick7,8, D Rintell2,4.
Abstract
Multiple sclerosis (MS) is a lifelong disease typically affecting individuals in young to middle adulthood. There are recognized sex differences in MS onset and clinical course. MS affects approximately three times more women than men, thus resulting in less attention to the male experience (i.e. diagnosis, management, societal dimensions). Here, we review current scientific evidence on sex differences in MS risk and course, highlight potential sources of bias, and suggest avenues of further inquiry. We then describe what is known about male experiences with MS diagnosis, treatment, and symptom management (particularly mood and sexual function). Finally, we consider ways in which healthcare providers might engage male patients in the broader aspects of living with MS (e.g. familial and societal relationships) to influence their long-term quality of life (QOL). When possible, we draw from published sources to underscore our collective clinical and scientific experiences.Entities:
Keywords: Depression; Gender; Quality of life; Sex difference; Sexual function; Suicide
Mesh:
Year: 2016 PMID: 26725085 DOI: 10.1007/s00415-015-8005-z
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849